prof. dr. G.N. (Gert) Moll

Honorary professor Protein Modification and Functionality

No picture available


Research units:

Postal address:
9747 AG
Phone: +31 50 363 4468Fax: +31 50 363 2368
  1. LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study

    Namsolleck, P., Richardson, A., Moll, G. N. & Mescheder, A., 27-Nov-2020, In : Peptides. 136, 170468.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Export and modification of (poly)peptides in the lantibiotic way

    Moll, G. N., Leenhouts, C. J., Kuipers, O. P. & Driessen, A. J. M., 4-Dec-2003, Patent No. WO03099862, 26-May-2003, Priority date 24-May-2002

    Research output: Patent

  3. Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors

    Moll, G. N., Kuipers, A., Rink, R., Bosma, T., de Vries, L. & Namsolleck, P., 14-Oct-2020, In : Biochemical Society Transactions. 48, 5, p. 2195-2203 9 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  4. Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?

    Namsolleck, P. & Moll, G. N., 17-Aug-2020, In : Molecular medicine. 26, 1, 5 p., 80.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. High-throughput screening for substrate specificity-adapted mutants of the nisin dehydratase NisB

    Zhao, X., Cebrian, R., Fu, Y., Rink, R., Bosma, T., Moll, G. N. & Kuipers, O. P., 19-Jun-2020, In : ACS Synthetic Biology. 9, 6, p. 1468-1478 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (48) »

  1. Kiemprijs 2014

    Moll, Gert (Recipient), 18-Nov-2014


View all (1) »

Press / Media
  1. Uit RUG voortgekomen Lanthio Pharma Chemische Start-up van het Jaar

    Gert Moll


    1 item of Media coverage

    Press/Media: Public Engagement ActivitiesPopular

View all (1) »

ID: 117694